Nutritional supplement for Non-Small Cell Lung Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cross Cancer Institute, Edmonton, CanadaNon-Small Cell Lung CancerNutritional supplement - DietarySupplement
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is looking at whether a nutritional product has an effect on patients with non-small cell lung cancer who are also receiving immunotherapy or a combination of immunotherapy and chemotherapy.

Eligible Conditions
  • Non-Small Cell Lung Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 14 Secondary · Reporting Duration: Analysis will occur once 1-year survival data has been collected for all study participants.

Analysis will occur once 1-year survival data has been collected for all study participants.
1-year survival
Progression-free survival
Day 30
Change in Fatty Acid Incorporation and Omega-3 Index
Chemotherapy-induced toxicities
Systemic therapy-induced toxicities
Day 30
Changes in Quality of Life
Changes in Quality of Life via FAACT
Changes in Quality of Life via PROMIS Global Health Scale
Changes in Quality of Life via PROMIS Physical Function Short Form
Changes in Quality of Life via Taste and Smell Survey
Upon completion of 2 cycles of treatment (each cycle is 21-days)
Disease Control Rate after 2 cycles
Day 21
Change in Serum Albumin
Change in Serum CRP
Change in skeletal muscle mass and adipose tissue
Upon completion of 4 cycles of treatment (each cycle is 21-days)
Disease control rate

Trial Safety

Trial Design

2 Treatment Groups

Experimental intervention
1 of 2
Non-experimental intervention
1 of 2

Experimental Treatment

Non-Treatment Group

60 Total Participants · 2 Treatment Groups

Primary Treatment: Nutritional supplement · Has Placebo Group · N/A

Experimental interventionExperimental Group · 2 Interventions: Nutritional supplement, Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) · Intervention Types: DietarySupplement, DietarySupplement
Non-experimental intervention
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nutritional supplement
2011
Completed Phase 4
~480

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: analysis will occur once 1-year survival data has been collected for all study participants.

Who is running the clinical trial?

AHS Cancer Control AlbertaLead Sponsor
180 Previous Clinical Trials
36,221 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is recruitment still happening for this experiment?

"Affirmative, according to clinicaltrials.gov the study is looking for 60 volunteers and was posted on November 30th 2022 with a final edit made on December 1st 2022. The research will be conducted in one medical facility." - Anonymous Online Contributor

Unverified Answer

How many participants are participating in this clinical research?

"Affirmative. According to the information located on clinicaltrials.gov, recruitment for this medical trial is ongoing since its inception on November 30th 2022 and last update December 1st of that year. 60 participants are sought after at a single site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.